Solution for injection sterile, clear, colorless, which has preservatives and comes as insulin U 100, which contains 100 units of insulin glargine per milliliter (1 mL = 1 cc)

2 trials

Sponsors

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,

Unknown Phase

A PHASE III CLINICAL TRIAL TO STUDY THE SAFETY AND EFFICACY OF MK-1293 COMPARED TO LANTUS™ IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,

Start: 2014-03-05Target: 60Updated: 2023-09-04

A PHASE III CLINICAL TRIAL TO STUDY THE SAFETY AND EFFICACY OF MK-1293 COMPARED TO LANTUS™ IN SUBJECTS WITH TYPE 1 DIABETES MELLITUS

Active, not recruitingPER-060-13

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,

Start: 2014-03-05Target: 90Updated: 2023-09-04